http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105439900-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_122bbcbc574a179c8e4e5eb17c0dae56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-35
filingDate 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8945730e366d5f6b5a4db4547d4e2572
publicationDate 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105439900-A
titleOfInvention Synthesis method of pyrimethamine drug intermediate p-chlorobenzonitrile
abstract The invention relates to a synthesis method of a pyrimethamine drug intermediate p-chlorobenzonitrile, which comprises the following steps: adding 1.3 mol of p-benzyl chloride and 0.56 mol of stannous chloride into a reaction vessel which is provided with a stirrer, a thermometer, a reflux condenser and a dropping funnel, controlling the stirring rate at 130-160 rpm, heating the solution to 90-95 DEG C, slowly and dropwisely adding 1.5-1.7 mol of cyanamide within 1-2 hours, continuing stirring to react for 4-5 hours, cooling the solution to 10-15 DEG C, adding 230ml of sodium chloride solution, separating out the water layer, washing the oil layer with a salt solution, washing with acetonitrile, carrying out reduced pressure distillation, and recrystallizing the fraction in ethyl acetate to obtain the crystal p-chlorobenzonitrile, wherein the mass percent of the sodium chloride solution is 15-20%, and the salt solution is any one of potassium bromide and sodium nitrate.
priorityDate 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5855
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5833
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448924711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444742
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425819623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453492911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449731539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID253877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447740608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550149

Total number of triples: 44.